Discontinued — last reported Q4 '24
Operating
Net gains (losses) on investments
Biogen Net gains (losses) on investments increased by 3900.0% to $19.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 146.5%, from -$40.90M to $19.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ4 2024
How to read this metric
Positive values indicate successful investment management, while negative values reflect market volatility or poor asset performance.
Detailed definition
This captures the non-cash gains or losses realized from the sale or revaluation of equity investments and securities. I...
Peer comparison
Common for large corporations with diversified portfolios or strategic minority stakes.
Metric ID:
gain_loss_on_investmentsHistorical Data
15 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$426.90M | -$116.30M | -$191.10M | -$78.20M | -$105.60M | -$79.60M | $106.40M | -$302.50M | -$1.40M | -$31.30M | -$30.30M | -$78.70M | -$40.90M | -$500.00K | $19.00M |
| QoQ Change | — | +72.8% | -64.3% | +59.1% | -35.0% | +24.6% | +233.7% | -384.3% | +99.5% | <-999% | +3.2% | -159.7% | +48.0% | +98.8% | >999% |
| YoY Change | — | — | — | — | +9.2% | +58.3% | +236.1% | — | +98.7% | +60.7% | -128.5% | <-999% | -30.7% | — | +146.5% |
Range-$426.90M – $106.40M
CAGR-58.9%
Avg YoY Growth-563.5%
Median YoY Growth+58.3%
Current Streak3 quarters growth
Product Breakdown
| Segment | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q3 '22 |
|---|---|---|---|---|---|
| ADUHELM | $45.00M | $45.00M | $45.00M | $59.00M | $41.00M |
| Total | — | -$426.90M | -$116.30M | -$191.10M | — |
Net gains (losses) on investments at Other Companies
Frequently Asked Questions
- What is Biogen's net gains (losses) on investments?
- Biogen (BIIB) reported net gains (losses) on investments of $19.00M in Q1 2026.
- How has Biogen's net gains (losses) on investments changed year-over-year?
- Biogen's net gains (losses) on investments increased by 146.5% year-over-year, from -$40.90M to $19.00M.
- What does net gains (losses) on investments mean?
- The profit or loss made from selling or holding financial investments.